Research behind a drug compound that causes complete remission of a leukemia subtype in mouse models has recently spurred a human clinical trial.

Breast cancer patients who test positive for an inherited genetic mutation, such as having the BRCA1 or BRCA2 gene, may be receiving treatment based on future cancer risk, rather than guideline approved treatments for their diagnosed cancers, study finds.

Glioblastoma is a deadly brain cancer with little treatment options available, but Michigan Medicine researchers are working in the lab to change that.

New basic science and clinical research identifies TAU, the same protein studied in the development of Alzheimer’s, as a biomarker for glioma development.

Since receiving a rare brain cancer diagnosis, one patient describes how her care plan at Michigan Medicine to treat her oligodendroglioma has helped, and how she is now helping others around her.

Neuropathologists are creating a partnership with AI by teaching it how to help diagnose brain tumors with more speed, accuracy and efficiency.

The most read stories of 2019 on the Michigan Health Lab blog.

A U-M law student, who passed of breast cancer in 2019, is remembered by her family and school in a special way.

After becoming pregnant, getting cancer, having heart failure and two strokes, one mother reflects back on her care team and her faith which pulled her through.

After being diagnosed with an aggressive brain tumor, Kathy Bellmore has outlived her initial prognosis, and is going strong.

New autoimmune disorder research may provide clues as to why TNF inhibitors, the drugs used to treat these diseases, carry serious infection and cancer risks.

While undergoing cancer treatments, six-year-old finds a lifelong talent and gift through painting.

Mammograms, an essential part of breast cancer screening, could increase overall health outcomes if performed annually according to a new study.

New breast implant guidelines proposed by the FDA would require patient decision checklists to aid in patient education.

Researchers devise new approach to find drug-activity biomarkers in fight against triple-negative breast cancer.